Our brains are the key to who we are
Contribute to the development of a cure for Alzheimer’s
It is an exciting time for research into Alzheimer’s disease and other causes of mild cognitive impairment (MCI) and dementia.
Results from clinical trials are always encouraging, bringing us ever closer to treatments to slow down or, ideally, halt the progression of the disease and to improve its symptoms.
World-class medical care for free
Volunteers receive outstanding medical care and are monitored regularly throughout the study by our team of brain and mental health experts. All medical costs are covered by the pharmaceutical company, so the very best care and medical facilities are provided at no cost to the individual.
Help us beat this devastating disease
Clinical trials are essential for advancing our understanding of medicine and improving the healthcare and quality of life for everyone affected by dementia and cognitive impairment.
Early access to new-generation medications
By participating in an international clinical study, you can gain the potential personal benefit of early access to a new treatment, whilst also having an important global impact on our ability to treat a given condition.
Global leader in enrolling volunteers onto clinical trials
Led by award-winning consultant neuroradiologist, Dr Emer MacSweeney, the Re:Cognition Health Clinical Trials team is proud of the pioneering work being undertaken by the consultants and cognitive experts at our clinics.
That’s why we continue to work hard to become one of the most successful clinics in the world for enrolling individuals onto final phase international clinical trials for Alzheimer’s Disease.
The welfare of our patients is at the heart of what we do
We have one goal: to help find a cure for Alzheimer’s Disease.